Compare CSPI & BDSX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | CSPI | BDSX |
|---|---|---|
| Founded | 1968 | 2005 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | EDP Services | Precision Instruments |
| Sector | Technology | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 107.1M | 122.0M |
| IPO Year | 1994 | 2020 |
| Metric | CSPI | BDSX |
|---|---|---|
| Price | $9.17 | $13.29 |
| Analyst Decision | | Strong Buy |
| Analyst Count | 0 | 5 |
| Target Price | N/A | ★ $32.50 |
| AVG Volume (30 Days) | 11.9K | ★ 55.4K |
| Earning Date | 05-13-2026 | 05-12-2026 |
| Dividend Yield | ★ 1.32% | N/A |
| EPS Growth | ★ 75.00 | N/A |
| EPS | ★ 0.01 | N/A |
| Revenue | $58,730,000.00 | ★ $88,499,000.00 |
| Revenue This Year | N/A | $25.26 |
| Revenue Next Year | N/A | $19.15 |
| P/E Ratio | $908.00 | ★ N/A |
| Revenue Growth | 6.36 | ★ 24.08 |
| 52 Week Low | $7.55 | $0.25 |
| 52 Week High | $17.76 | $20.21 |
| Indicator | CSPI | BDSX |
|---|---|---|
| Relative Strength Index (RSI) | 55.11 | 43.74 |
| Support Level | $8.89 | $6.00 |
| Resistance Level | $9.09 | $16.26 |
| Average True Range (ATR) | 0.54 | 1.04 |
| MACD | 0.12 | -0.22 |
| Stochastic Oscillator | 61.57 | 26.76 |
CSP Inc develops and markets IT integration solutions, security products, managed IT services, cloud services, purpose-built network adapters, and high-performance cluster computer systems. The firm operates in two segments, namely Technology Solutions, where the company focuses on value-added reseller integrated solutions, including third-party hardware, software, and technical computer-related consulting, and High-Performance Products segments, where the company designs, manufactures, and delivers products and services to customers that require specialized cybersecurity services, networking, and signal processing. It generates a majority of its revenue from the Technology Solutions segment. Geographically, the company generates the majority of its revenue from the Americas.
Biodesix Inc is a diagnostic solutions company with a focus in lung disease. The Company has a single operating segment focused on providing diagnostic testing services to customers. It provides biopharmaceutical companies with services that include diagnostic research, clinical trial testing, and the discovery, development, and commercialization of companion diagnostics. The revenue is derived from two sources, providing diagnostic testing services associated with blood-based lung and Covid tests; and providing biopharmaceutical companies with services generally provided outside the clinical setting and governed by individual contracts with third parties as well as development and commercialization of companion diagnostics.